Community post
Dinesh Subedi (Monash University) and colleagues have developed a five-phage cocktail, Entelli-02 against 156 clinical Enterobacter cloacae complex strains from the Alfred Hospital in Melbourne. They show that Entelli-02 exhibits broad host coverage (99%) and efficacy (92%), and have produced it as a therapeutic-grade product, verified and endotoxin unit-compliant, ready for use.
Topics
| Source | Capsid & Tail #272 |
|---|